vom 02/14/2018

World Cancer Day 2018: The NCT Heidelberg invites you to a closing night and supports research projects though an auction

World Cancer Day focuses on prevention / The NCT Heidelberg is hosting an auction in support of preventative oncology / Invitation to the closing night of the exhibition “espressivo“

We can. I can! – The World Cancer Day on the 4th of February is themed to remind everyone that they can do something in the fight against cancer. The National Center for Tumor diseases (NCT) Heidelberg supports this concern and invites you to an auction and the closing night of the exhibition “espressivo” on February 5th at the NCT. The NCT Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), the Heidelberg University Hospital (Universitätsklinik Heidelberg) and the German Cancer Aid (Deutsche Krebshilfe).

The World Cancer Day has been established in 2006 and is held on February 4th. It was initiated by the Union for International Cancer Control (UICC) and the World Health Organization (WHO) in order to raise awareness of cancer treatment, research and prevention in the public eye. This year’s theme is “We can. I can!” and it is meant to call attention to the fact that everyone can help lower their individual risk of getting cancer by living a healthy lifestyle and by going to early detection examinations.

The NCT Heidelberg supports the strengthening of cancer prevention. In this effect there will be an online auction until February 11th 11:59 pm. The money raised will be used for funding of prevention programs at the NCT Heidelberg. Prospective buyers can bid on objects that were donated by the NCT. These objects include but are not limited to: two VIP tickets to the German Soccer League home game of 1899 Hoffenheim against Hannover 96 in April and a signed shirt from table tennis star Timo Boll. Objects can be found under: www.nct-heidelberg.de/auktion.

The NCT invites every prospective buyer to take part in the auction. The object goes to the highest bidder and will be registered as a donation to the NCT. Bids can be submitted by e-mail. The donations will be used for cancer prevention research projects. There won’t be any costs for bidders who couldn’t be considered.

If you are interested in taking part please write an e-mail including the information on the desired object and the highest bid (spenden@nct-heidelberg.de). In case of equal offers bidders will be asked to raise their offers. In case of another tie, the earliest submitted bid wins.

Invitation to the closing night
One of the objects for the auction will be a photograph that was taken at the “1,174 beats against cancer” charity concert in September 2017. It was taken by photographer and NCT patient Armin Habermann, who put together a total of 13 photos from the concert to the "espressivo" exhibition in the NCT premises. One picture with the measurements 105x70 cm can be purchased by auction at a minimum bid of 300 Euro in favor of the NCT.On the occasion of the World Cancer Day the NCT invites all interested parties to the official end of the exhibition of Armin Habermann’s photographs on Monday, February 5th, from 3 to 5 pm. The artist as well as professor Dirk Jäger, executive and medical director at the NCT, will address some introductory words to the guests at the beginning. The event will be accompanied musically by the flutist Philipp Mellies.

Further information about the closing night and about the auction can be found on the NCT homepage (www.nct-heidelberg.de/auktion).

The Image for press release is available free of charge on the internet:
This picture is part of the exhibition “espressivo” and will be auctioned off (minimum bid 300 Euros) in favor of the NCT. Bids can be submitted via email (spenden@nct-heidelberg.de) until February 11th.

Tour of the exhibition:

Instructions for use of image material for press releases
Usage is free of charge. The NCT Heidelberg allows one-time use in connection with reporting on the topic of this press release. Please use credits as follows: "Source: Armin Habermann". A transfer of the image material to third parties is permitted only after prior consultation with the NCT Press Office (Tel. 06221 56 5930, E-Mail: friederike.fellenberg@nct-heidelberg.de). Use for commercial purposes is prohibited.

Press contacts: Dr. Friederike Fellenberg, Dr. Sibylle Kohlstädt, Doris Rübsam-Brodkorb

The National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center, Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. 2015 the NCT Heidelberg established a partner location in Dresden.

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
The German Cancer Research Center (DKFZ) with its more than 3,000 employees is the largest biomedical research institute in Germany. At DKFZ, more than 1,000 scientists investigate how cancer develops, identify cancer risk factors and endeavor to find new strategies to prevent people from getting cancer. They develop novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful. The staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public. Jointly with Heidelberg University Hospital, DKFZ has established the National Center for Tumor Diseases (NCT) Heidelberg, where promising approaches from cancer research are translated into the clinic. In the German Consortium for Translational Cancer Research (DKTK), one of six German Centers for Health Research, DKFZ maintains translational centers at seven university partnering sites. Combining excellent university hospitals with high-profile research at a Helmholtz Center is an important contribution to improving the chances of cancer patients. DKFZ is a member of the Helmholtz Association of National Research Centers, with ninety percent of its funding coming from the German Federal Ministry of Education and Research and the remaining ten percent from the State of Baden-Württemberg.

Heidelberg University Hospital and Medical Faculty Heidelberg
Heidelberg University Hospital is one of the most important medical centers in Germany; Heidelberg University's Medical Faculty is one of Europe's most prestigious biomedical research facilities. Their shared objective is the development of innovative diagnostics and treatments and their prompt implementation for the benefit of the patient. The hospital and faculty employ approximately 12 600 individuals and are involved in training and qualification. Every year approximately 66 000 patients are treated as inpatients or day patients in more than 50 specialized clinical departments with about 1 900 beds, with more than 1 million patients being treated as outpatients. The Heidelberg Curriculum Medicinale (HeiCuMed) is at the forefront of medical training in Germany. At present approx. 3500 prospective physicians are studying in Heidelberg.